Kolexia
Rascol Olivier Neurologie
Rascol Olivier
Neurologie
Labo Pharmacol Med Et Clinique
Toulouse, France
424 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Parkinson Atrophie Atrophie multisystématisée Dyskinésies Dyskinésie due aux médicaments Syndromes parkinsoniens Troubles de la motricité Hypotension orthostatique Syndrome de Shy-Drager

Collaborateurs

Voir plus
Meissner Wassilios
Meissner Wassilios
Hôpital Pellegrin, Bordeaux, France
Ory-Magne Fabienne
Ory-Magne Fabienne
Hôpital Purpan, Toulouse, France
Corvol Jean-Christophe
Corvol Jean-Christophe
Hôpital Pitie Salpetriere, Paris, France
Brefel-Courbon Christine
Brefel-Courbon Christine
Hôpital Purpan, Toulouse, France

Industries

Voir plus
Orion Pharma
8 collaboration(s)
Dernière en 2023
Parexel
6 collaboration(s)
Dernière en 2022
CEMKA
5 collaboration(s)
Dernière en 2023
Kyowa Kirin
5 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
LUMA: A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122 in Participants With Parkinson's Disease
Essai Clinique (Biogen)   15 mars 2024
ACTIVATE: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in Subjects With Parkinson's Disease With a Pathogenic Variant in the Glucocerebrosidase (GBA1) Gene
Essai Clinique (Bial R&D Investments, S.A.)   13 mars 2024
Patient-perceived progression in multiple system atrophy: natural history of quality of life.
Journal of neurology, neurosurgery, and psychiatry   07 mars 2024
Recent Advances in Clinical Trials in Multiple System Atrophy.
Current neurology and neuroscience reports   28 février 2024
A Study of TAK-341 in Treatment of Multiple System Atrophy: A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous TAK-341 in Subjects With Multiple System Atrophy
Essai Clinique (Takeda Pharmaceutical)   26 février 2024
Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson's disease (ROCK-PD).
Frontiers in aging neuroscience   14 février 2024
The impact of subthalamic deep-brain stimulation in restoring motor symmetry in Parkinson's disease patients: a prospective study.
Journal of neurology   09 février 2024
A Double-Blind, Randomized, Placebo-Controlled Trial of Bumetanide in Parkinson's Disease.
Movement disorders : official journal of the Movement Disorder Society   30 janvier 2024
ON/OFF non-motor evaluation: a new way to evaluate non-motor fluctuations in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry   25 janvier 2024
Prognosis of impulse control disorders in Parkinson's disease: a prospective controlled study.
Journal of neurology   12 janvier 2024